Australian Pregnancy Care Guidelines

Published by Living Evidence for Australian Pregnancy and Postnatal Care (LEAPP) on Jun 25, 2024

View

Disclaimer

Sponsors

This guideline is funded by the Australian Government Department of Health and Aged Care.

Contact

Abstract

Language

en-au

PICOS

PICO 10.1

Population
Pregnant women with normal iron status
Intervention
Oral Iron Supplementation
Comparator
No Oral Iron Supplementation
Outcomes

PICO 10.2

Population
Pregnant women with or without anaemia
Intervention
Supplementation with iron alone
Comparator
no treatment/placebo
Outcomes

PICO 10.3

Population
Pregnant women
Intervention
Intermittent oral iron alone supplementation
Comparator
daily iron alone supplementation
Outcomes

PICO 10.4

Population
Pregnant women with iron deficiency anaemia
Intervention
Intravenous iron
Comparator
Oral Iron
Outcomes

PICO 10.5

Population
Pregnant women
Intervention
Ferrous biglycinate
Comparator
Other iron supplements
Outcomes

PICO 20.1

Population
Pregnant women
Intervention
Edinburgh Postnatal Depression Scale
Comparator
Other depression diagnosis tools or scales
Outcomes

PICO 30.1

Population
Women who are pregnant or are planning pregnancy
Intervention
Consumption of alcohol
Comparator
Abstinence
Outcomes

PICO 30.1

Population
Among pregnant women
Intervention
One step testing approach
Comparator
two steps testing approach
Outcomes

PICO 30.1

Population
Pregnant women
Intervention
Validated anxiety assessment tools
Comparator
Any other tool or any scale of a given tool
Outcomes

PICO 40.1

Population
Pregnant women with gestational age>=24 weeks
Intervention
Encouraging awareness of fetal movement
Comparator
Standard care
Outcomes

PICO 40.1

Population
Pregnant women
Intervention
Validated psychosocial assessment tools
Comparator
Any other tool or any scale of a given tool
Outcomes

PICO 50.1

Population
All pregnant women
Intervention
Universal cervical length screening
Comparator
No screening/high risk screening
Outcomes

PICO 50.2

Population
Pregnant women
Intervention
Diagnostic accuracy test of cervical length
Comparator
any alternative test
Outcomes

PICO 50.3

Population
Pregnant women at risk of preterm birth
Intervention
Progesterone/cerclage
Comparator
placebo/no progesterone/no cerclage
Outcomes

PICO 50.4

Population
Pregnant women with short cervix(<10mm)
Intervention
Cerclage
Comparator
No cerclage
Outcomes

PICO 50.5

Population
Pregnant women with specific high risk factors
Intervention
Progesterone/cervical cerclage
Comparator
Placebo/no cerclage/ alternative cerclage
Outcomes

PICO 50.6

Population
Women with 3 or more preterm
Intervention
Any intervention
Comparator
no intervention/alternative intervention
Outcomes

PICO 50.7

Population
Women with threatened miscarriage and/or recurrent miscarraige
Intervention
Micronized vaginal progesterone
Comparator
Placebo
Outcomes

PICO 50.8

Population
Women at risk of miscarriage
Intervention
Progesterone
Comparator
Placebo
Outcomes

PICO 50.9

Population
Pregnant women at risk of preterm birth
Intervention
Progesterone
Comparator
Cervical cerclage
Outcomes

PICO 100.1

Population
Pregnant women prior to 16 weeks gestation
Intervention
Aspirin
Comparator
Placebo
Outcomes

PICO 100.2

Population
Pregnant women
Intervention
Preeclampsia screening
Comparator
Standard care
Outcomes

PICO 100.3

Population
Pregnant women between 11+0 to 14+1 weeks gestation
Intervention
Diagnostic test accuracy for pre-eclampsia risk at any gestation
Comparator
Alternative test/s
Outcomes

PICO 100.4

Population
Pregnant women at risk of preeclampsia
Intervention
Aspirin 150mg commenced prior to 16 weeks gestation
Comparator
Aspirin 100mg or less
Outcomes

PICO 100.5

Population
Pregnant women commenced on aspirin prior to 16 weeks gestation
Intervention
Evening dose timing
Comparator
Other time
Outcomes

PICO 100.6

Population
Nulliparous women at low risk of preeclampsia
Intervention
Aspirin
Comparator
No aspirin
Outcomes

PICO 100.7

Population
Pregnant women with suspected preeclampsia
Intervention
Urinalysis
Comparator
Alternative urinalysis
Outcomes

PICO 100.8

Population
Pregnant women
Intervention
Low molecular weight heparin (LMWH) + Aspirin
Comparator
Aspirin alone
Outcomes

PICO 100.9

Population
Pregnant women
Intervention
Low molecular weight heparin
Comparator
Placebo
Outcomes